Treatment of amyotrophic lateral sclerosis (ALS)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12116589
APP PUB NO 20230323388A1
SERIAL NO

17881193

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and/or canine degenerative myelopathy (DM).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE CURATORS OF THE UNIVERSITY OF MISSOURI316 UNIVERSITY HALL COLUMBIA MO 65211

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Qingmin Belmont, US 26 238
Coates, Joan R Columbia, US 5 11
Hou, Jinzhao Lexington, US 71 308
Patzke, Holger Cambridge, US 20 63
Sah, Dinah Wen-Yee Hopkinton, US 85 907

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 15, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 15, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 15, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00